Search Results - "Wæhre, H"

Late recurrences of germ cell malignancies: a population-based experience over three decades by OLDENBURG, J, ALFSEN, G. C, WAEHRE, H, FOSSA, S. D

“…The purpose of this study was to explore the incidence of late relapse in patients with malignant germ cell tumour (MGCT) in a population-based series, with…”
Get full text

495 Divergent androgen regulation of UPR pathways drives prostate cancer by Arnoldussen, Y.J, Storm, M, Sheng, X, Tesikova, M, Jin, Y, Nenseth, H.Z, Zhao, S, Mills, I.G, Fazli, L, Rennie, P, Risberg, B, Wæhre, H, Danielsen, H.E, Hotamisligil, G.S, Saatcioglu, F

Get full text

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens by BERNER, A, NESLAND, J. M, WÆHRE, H, SILDE, J, FOSSÅ, S. D

“…Pre- and post-treatment specimens from 47 patients with hormone resistant prostatic carcinoma were compared with each other regarding histological grade and…”
Get full text

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients by MU, L. J, KYTE, J. A, KVALHEIM, G, AAMDAL, S, DUELAND, S, HAUSER, M, HAMMERSTAD, H, WAEHRE, H, RAABE, N, GAUDERNACK, G

“…Here, we present results from a clinical trial employing a new vaccination method using dendritic cells (DCs) transfected with mRNA from allogeneic prostate…”
Get full text

The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy by Clobes, H., Fosså, S. D., Wæhre, H., Jocham, D., Berner, A.

“…Objective To detect occult regional lymph node metastases in patients with T3pN0M0 prostate cancer not recognized by routine haematoxylin and eosin staining,…”
Get full text

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy by Lilleby, W, Fosså, S D, Waehre, H R, Olsen, D R

“…To assess morbidity, side effects, and quality of life (QoL) in patients treated for localized prostate cancer with curative aim. This descriptive…”
Get more information

DNA ploidy in primary testicular cancer by FOSSA, S. D, NESLAND, J. M, PETTERSEN, E. O, AMELLEM, Ø, VÆHRE, H, HEIMDAL, K

“…The DNA stemline ploidy was measured by flow cytometry (FCM) in 129 samples from paraffin-embedded primary testicular tumours (61 seminomas, 68 non-seminomas)…”
Get full text

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection by JACOBSEN, K. D, OUS, S, WAEHRE, H, TRASTI, H, STENWIG, A. E, LIEN, H. H, AASS, N, FOSSA, S. D

“…The purpose of this study was to evaluate fertility after different types of post-chemotherapy retroperitoneal lymph node dissection (RPLND). During 1980-1994,…”
Get full text

Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer by Guren, M.G, Wiig, J.N, Dueland, S, Tveit, K.M, Fosså, S.D, Wæhre, H, Giercksky, K.-E

“…Aims: When locally advanced or recurrent rectal cancer involves the bladder or prostate, curative treatment often requires pelvic exenteration. The aim was to…”
Get full text

Radical prostatectomy for locally advanced primary or recurrent rectal cancer by Wiig, J.N, Wæhre, H, Larsen, S.G, Brændengen, M, Giercksky, K.-E

“…Aim: Three papers including five patients have described en bloc radical prostatectomy for locally advanced rectal cancer. Methods: Six patients (median age 63…”
Get full text

Tumour heterogeneity poses a significant challenge to cancer biomarker research by Cyll, Karolina, Ersvær, Elin, Vlatkovic, Ljiljana, Pradhan, Manohar, Kildal, Wanja, Avranden Kjær, Marte, Kleppe, Andreas, Hveem, Tarjei S, Carlsen, Birgitte, Gill, Silje, Löffeler, Sven, Haug, Erik Skaaheim, Wæhre, Håkon, Sooriakumaran, Prasanna, Danielsen, Håvard E

“…Background: The high degree of genomic diversity in cancer represents a challenge for identifying objective prognostic markers. We aimed to examine the extent…”
Get full text

Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement by Opjordsmoen, S, Waehre, H, Aass, N, Fossa, S D

“…To evaluate sexuality after successful treatment of penile cancer. Post-therapy sexuality was evaluated in 30 men (median age 57 years; range 28-75) treated…”
Get more information

Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer by FOSSÅ, S. D, BERNER, A. A, PETTERSEN, E. O, JACOBSEN, A.-B, WÆHRE, H, KVARSTEIN, B, URNES, T, ØGREID, P, BJERKLUND JOHANSEN, T. E, SILDE, J, NESLAND, J. M

“…DNA ploidy and S-phase fraction (SPF), determined by flow cytometry were studied in 118 patients with muscle-invasive transitional cell carcinoma (TCC) of the…”
Get full text

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer by FOSSA, S. D, WAEHRE, H, PAUS, E

“…Twenty-seven of 152 patients (18%) with progressing hormone resistant prostate cancer had normal serum levels of prostate specific antigen (PSA less than or…”
Get full text

Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor Masses by OLDENBURG, Jan, ALFSEN, G. Cecilie, LIEN, Hans H, AASS, Nina, WAEHRE, Hakon, FOSSA, Sophie D

“…To determine preoperative parameters that predict the histology of specimens obtained by retroperitoneal lymph node dissection (RPLND) in patients with…”
Get full text

Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study by Fosså, S D, Dingsør, E, Johannessen, N B, Kvarstein, B, Stenwig, A E, Urnes, T, Waehre, H, Ogreid, P

“…Fourteen patients with muscle infiltrating bladder cancer in whom total cystectomy was planned, received 3 cycles of cis-platinum (70 mg/m2 Day 1) and…”
Get more information

Long-term morbidity and quality of life in testicular cancer patients by Fosså, S D, Aass, N, Ous, S, Waehre, H

“…Today about 90% of patients with testicular cancer can be cured. The consideration of treatment-related long-term morbidity has, therefore, become an important…”
Get more information

Dendritic cells transfected with allo-tumor mRNA as cancer vaccine in treatment of hormone resistant prostate cancer patients by Dueland, S., Mu, L.-J., Kvalheim, G., Hauser, M., Waehre, H., Aamdal, S., Gaudernack, G.

“…Abstract only…”
Get full text

Genomic analysis of prostate carcinoma specimens obtained via ultrasound‐guided needle biopsy may be of use in preoperative decision‐making by Teixeira, Manuel R., Ribeiro, Franclim R., Eknæs, Mette, Wæhre, Håkon, Stenwig, Anna E., Giercksky, Karl E., Heim, Sverre, Lothe, Ragnhild A.

“…BACKGROUND The widespread use of prostate‐specific antigen (PSA) testing to screen for prostate carcinoma has led to significant overdiagnosis, due to the…”
Get full text

Brachytherapy for Prostate Cancer: A Systematic Review of Clinical and Cost Effectiveness by Norderhaug, Inger, Dahl, Olav, Høisæter, Per Å., Heikkilä, Reino, Klepp, Olbjørn, Olsen, Dag Rune, Kristiansen, Ivar S., Wæhre, Håkon, Bjerklund Johansen, Truls E.

“…Objectives: Brachytherapy is emerging as a new treatment option for prostate cancer, and is increasingly being used in Europe and North America. Methods: A…”
Get full text